Effect of rimantadine on induced specific serum haemagglutination-inhibiting antibody and nasal IgA titres after experimental exposure of adults to influenza A virus

Antiviral Therapy

Volumn 3, Issue 1, 1998, Pages 19-23

  Doyle, William J ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMAGGLUTINATION INHIBITING ANTIBODY; IMMUNOGLOBULIN A ANTIBODY; NEUTRALIZING ANTIBODY; PLACEBO; RIMANTADINE;

ADULT; ANTIBODY TITER; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; INFLUENZA VIRUS A; MAJOR CLINICAL STUDY; MALE; OTORHINOLARYNGOLOGY; PRIORITY JOURNAL; SEROCONVERSION; SERUM; VIRUS LOAD; VIRUS SHEDDING;

EID: 0031924285     PISSN: 13596535     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Wingfield WL, Pollak D & Grunert RR. Therapeutic efficacy of amantadine HCl and rimantadine HCl in naturally occurring influenza A2 respiratory illness in man. New England Journal of Medicine 1969; 281:579-584.
2. Monto AS, Gunn RA, Bandyk MG & King CL. Prevention of Russian influenza by amantadine. Journal of the American Medical Association 1979; 241:1003-1007.
3. Dolin R, Reichman RC, Madore HP, Maynard R, Linton, PN & Webber-Jones J. A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection. New England Journal of Medicine 1982; 307:580-584.
4. Payler DK & Prudham PA. Influenza A prophylaxis with amantadine in a boarding school. Lancet 1984; i:502-504.
5. Clover RD, Craw-ford SA, Abell TD, Ramsey CN Jr, Glezen WP & Couch RB. Effectiveness of rimantadine prophylaxis of children with families. American Journal of Diseases of Children 1986; 140:706-709.